Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
The Serum Hepatitis B Virus Large Surface Protein as High-Risk Recurrence Biomarker for Hepatoma after Curative Surgery.
Int J Mol Sci. 2022 May 11;23(10):5376. doi: 10.3390/ijms23105376.
Int J Mol Sci. 2022.
PMID: 35628188
Free PMC article.
Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination.
Shen CF, Yen CL, Fu YC, Cheng CM, Shen TC, Chang PD, Cheng KH, Liu CC, Chang YT, Chen PL, Ko WC, Shieh CC.
Shen CF, et al. Among authors: cheng kh.
Front Immunol. 2022 Jan 25;13:807454. doi: 10.3389/fimmu.2022.807454. eCollection 2022.
Front Immunol. 2022.
PMID: 35145520
Free PMC article.
Item in Clipboard
Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection.
Yen CJ, Ai YL, Tsai HW, Chan SH, Yen CS, Cheng KH, Lee YP, Kao CW, Wang YC, Chen YL, Lin CH, Liu T, Tsai HP, Wang JR, Su IJ, Huang W.
Yen CJ, et al. Among authors: cheng kh.
Hepatology. 2018 Sep;68(3):815-826. doi: 10.1002/hep.29790. Epub 2018 May 21.
Hepatology. 2018.
PMID: 29350774
Item in Clipboard
Cite
Cite